A Novel Computational Framework for Predicting the Survival of Cancer Patients With PD-1/PD-L1 Checkpoint Blockade Therapy

BACKGROUND: Immune checkpoint inhibitors (ICIs) induce durable responses, but only a minority of patients achieve clinical benefits. The development of gene expression profiling of tumor transcriptomes has enabled identifying prognostic gene expression signatures and patient selection with targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xiaofan, Jin, Haoxuan, Du, Ning, Wang, Jiaqian, Lu, Huiping, Xiao, Jinyuan, Li, Xiaoting, Yi, Jian, Gu, Tiantian, Dan, Xu, Gao, Zhibo, Li, Manxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271954/
https://www.ncbi.nlm.nih.gov/pubmed/35832540
http://dx.doi.org/10.3389/fonc.2022.930589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271954/
https://www.ncbi.nlm.nih.gov/pubmed/35832540
http://dx.doi.org/10.3389/fonc.2022.930589

Ejemplares similares